RegeSi

RegeSi
Product Description

RegeSi is a new generation of bioactive silicon-based regenerative medical material. Chemical Name: Calcium Phosphosilicate INCI name: Calcium Phosphosilicate CAS: 12737-17-6 Appearance: white powder Structure: amorphous structure Particle size: 5nm powder pH value: stable at 7.4 to 9 RegeSi is an inorganic non-metallic material with excellent bio-compatibility and bio-activity. It is the only new medical material that can bond and effectively promote the in-situ regeneration of human soft and hard tissue at the same time, and helpful to complete bone defect, bone repair and help tendon tissue transplantation and repair, and to achieve tissue regeneration in situ and grow close to the original tissue and cells. RegeSi contains essential elements such as calcium, phosphorus, silicon, and oxygen for the human body. It's a new type of artificially synthesized porous bio-active material with micro and nano structures. Application Area: - Bio-loaded scaffolds, cartilage repair, stem cell scaffolds, vascular scaffolds, targeted drug loaded scaffolds. - Artificial bone, bone injury, bone tumor (targeted drug delivery), cartilage repair for dental implantation, non load bearing bone filling repair; - Chronic Wounds, diabetes ulcers, diabetes foot ulceration, bedsore and other difficult wounds. - Ordinary wounds, such as cesarean section, cutting, and medical cosmetic surgery wound can heal quickly without or almost no scars. - In Vivo Mucosa, repair of uterine mucosa (prevent infertility), repair of abdominal respiratory tract, gastric ulcer mucosa, and reproductive mucosa. - Medical Beauty and Skin Care, breast implant, tissue regeneration and shaping, skin repair, promotes skin regeneration, anti-aging, and promotes hair growth. - Oral Cavity, dental & enamel restoration, prevention of gum recession, prevention of tooth decay, and prevention of oral ulcers.

Hangzhou Xinfu Science & Technology Co., Ltd.

  • CN
  • 2017
    On CPHI since

Hangzhou Xinfu Science & Technology Co., Ltd.

  • CN
  • 2017
    On CPHI since